Clinical trials
Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 3 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| St. Petersburg State Pavlov Medical University | 5 |
| Novartis Pharmaceuticals | 3 |
| Bristol-Myers Squibb | 2 |
| National Research Center for Hematology, Russia | 1 |
| Pfizer | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 13 |
| Myelodysplastic Syndromes | 5 |
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Myeloproliferative Disorders | 4 |
| Hematologic Diseases | 3 |
| Bone Marrow Diseases | 2 |
| Graft vs Host Disease | 2 |
| Leukemia, Myeloid | 2 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.